Skip to content

SCHEDULE 13GAccepted Mar 13, 4:02 PM ET

AN2 Therapeutics, Inc. SCHEDULE 13G

Vivo Opportunity Fund Holdings, L.P.

Accepted (ET)

4:02 PM

Mar 13, 2026

Filed

Mar 13, 2026

Documents

2

Size

19.8 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.